1.
Mansani FP, Koppen M. Pharmacoeconomic analysis of the genomic test Mammaprint® use for breast cancer patients treated at a private health institution in Brazil. MAST [Internet]. 2020 Apr. 12 [cited 2024 Nov. 12];30:1-3. Available from: https://revistamastology.emnuvens.com.br/revista/article/view/944